Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT02113592What this trial is testingPain Program for Active Coping & TrainingWho this might be right forChronic Non-malignant Pain Kaiser Permanente 850
Large-scale testing (Phase 3)Study completedNCT01400139What this trial is testingLong-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.Who this might be right forChronic Nonmalignant and Nonneuropathic Pain Purdue Pharma LP 922
Large-scale testing (Phase 3)Study completedNCT00415597What this trial is testingStudy of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant PainWho this might be right forPain Pfizer 467
Large-scale testing (Phase 3)Study completedNCT01993940What this trial is testingEfficacy and Safety of Naldemedine in Treating Opioid-induced ConstipationWho this might be right forOpioid-induced Constipation Shionogi 553
Not applicableWithdrawnNCT04235218What this trial is testingBrief-Illness Perception Questionnaire (Brief-IPQ) Used in Patients With Chronic Non-malignant Pain.Who this might be right forChronic Pain Syndrome Zealand University Hospital
Not applicableStudy completedNCT03981302What this trial is testingFamily Nursing Conversations Patients With Chronic Non-Cancer PainWho this might be right forChronic Nonmalignant Pain Bente Appel Esbensen 143
Testing effectiveness (Phase 2)Study completedNCT01443403What this trial is testingNaldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid TherapyWho this might be right forOpioid-induced Constipation Shionogi 244
Large-scale testing (Phase 3)Study completedNCT00226421What this trial is testingEfficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant PainWho this might be right forChronic Pain Endo USA Inc., a Keenova Therapeutics Company 120
Early research (Phase 1)Study completedNCT02880475What this trial is testingOXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant PatientsWho this might be right forChronic Pain Mundipharma (China) Pharmaceutical Co. Ltd 30
Large-scale testing (Phase 3)Study completedNCT01438567What this trial is testingDemonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer TherapyWho this might be right forPainConstipation Mundipharma Research GmbH & Co KG 270
Not applicableStudy completedNCT03043378What this trial is testingChronic Non-Malignant Pain in Cancer Patients at a Supportive Care ClinicWho this might be right forMalignant Neoplasms of Independent (Primary) Multiple Sites M.D. Anderson Cancer Center 201
Large-scale testing (Phase 3)Ended earlyNCT00126763What this trial is testingFentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant PainWho this might be right forPain ZARS Pharma Inc. 105
Post-approval studies (Phase 4)Study completedNCT00547885What this trial is testingRandomized Controlled Double Blind Trial of Short vs Long Acting Dihydrocodeine in Chronic Non-malignant PainWho this might be right forPain Norwegian University of Science and Technology 60
Large-scale testing (Phase 3)Study completedNCT00195728What this trial is testingLong Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant PainWho this might be right forModerate to Severe Chronic, Non-malignant Pain Abbott 431
Testing effectiveness (Phase 2)Ended earlyNCT00278824What this trial is testingFentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant PainWho this might be right forPain ZARS Pharma Inc. 109
Large-scale testing (Phase 3)Study completedNCT00412152What this trial is testingOxycodone-naloxone in Relieving Opioid-related ConstipationWho this might be right forPain Mundipharma Research GmbH & Co KG
Post-approval studies (Phase 4)Study completedNCT03761277What this trial is testingEmbrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic PainWho this might be right forChronic Non-malignant PainChronic PainPain, Back+1 more MedtronicNeuro 93
Large-scale testing (Phase 3)WithdrawnNCT01206907What this trial is testingEffectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric SubjectsWho this might be right forChronic Pain Endo USA Inc., a Keenova Therapeutics Company
Large-scale testing (Phase 3)Study completedNCT01965158What this trial is testingEfficacy and Safety of Naldemedine in the Treatment of Opioid-induced ConstipationWho this might be right forOpioid-induced Constipation Shionogi 547